Drugs represent the most common cause of platelet dysfunction in our overmedicated
society. While acetylsalicylic acid (aspirin), adenosine diphosphate receptor antagonists …

Although the exact prevalence of antiplatelet resistance in ischemic stroke is not known,
estimates about the two most widely used antiplatelet agents–aspirin and clopidogrel …

A high on-treatment residual ADP-inducible platelet reactivity in light transmission
aggregometry (LTA) has been associated with an increased risk of adverse outcomes after …

Aims Platelets play a key role in the pathophysiology of coronary artery disease (CAD) and
patients with enhanced platelet activation are at increased risk to develop adverse …

Background Platelets are key players in the pathophysiology of coronary artery disease
(CAD) and platelet hyperreactivity leads to increased risk of developing adverse …

Thrombosis of a drug-eluting stent (DES) is a catastrophic complication. The risk of stent
thrombosis (ST) is increased in the perioperative setting and is strongly associated with the …

Objectives: To identify the therapeutic regimens used at discharge in patients receiving oral
anticoagulant therapy (OAT) who undergo stenting percutaneous coronary intervention and …

Glycoconjugates extracted from Genipa americana leaves (PE-Ga) were separated into two
fractions, denominated as PFI and PFII (total carbohydrate: 23–36%/uronic acid: 9–30%; …

Abstract Background The BASE ACS randomized trial demonstrated non-inferiority of
titanium-nitride-oxide-coated bioactive stents (BAS), compared with everolimus-eluting …

BACKGROUND Previous research suggests uncertainty whether or not there is any
additional benefit in adding antiplatelet therapy (APT) to anticoagulation therapy (ACT) in …